Ainos, Inc. (AIMD) vs Satellos Bioscience Inc. (MSLE)

A side-by-side comparison of Ainos, Inc. and Satellos Bioscience Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Ainos, Inc. logo
AIMD
Ainos, Inc.
$10M
$1.32HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT
Satellos Bioscience Inc. logo
MSLE
Satellos Bioscience Inc.
$10M
$8.03HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT

Total return — AIMD vs MSLE

growth of $100 · dividends reinvested · last 1y
AIMD -28.5% (-28.5%/yr)MSLE +13.7% (+13.7%/yr)MSLE compounded faster over this window
100150Start $100$72$114
AIMD MSLE

AIMD vs MSLE: by the numbers

  • •MSLE is the larger company ($10M vs $10M market cap).
  • •Both run net losses; MSLE's is the smaller (0.00% vs -106283.32% net margin).

Metrics side by side

Valuation

MetricAIMDMSLE
P/S ratio714.79N/A
P/B ratio2.960.17

Profitability

MetricAIMDMSLE
Gross margin-3767.20%0.00%
Operating margin-11268.32%0.00%
Net margin-106283.32%0.00%
ROE-440.15%-57.34%
ROIC-80.51%-59.35%

Growth (annualized)

MetricAIMDMSLE
Revenue CAGR (5Y)49.62%N/A
Total return CAGR (5Y)-58.50%N/A

Go deeper

Full AIMD analysisFull MSLE analysisInteractive comparison tool

Dig into the metrics

Ainos ROESatellos Bioscience ROEAinos operating marginSatellos Bioscience operating marginAinos revenue growthSatellos Bioscience revenue growthAinos free cash flowSatellos Bioscience free cash flow

Ainos & Satellos Bioscience appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.